This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Nahas, Stephanie
| Item Type | Name |
|
Concept
|
Migraine Disorders
|
|
Academic Article
|
What might the ideal electronic medical record for migraine headache look like?
|
|
Academic Article
|
Chemical mediators of migraine: preclinical and clinical observations.
|
|
Academic Article
|
Triptans: actions and reactions.
|
|
Academic Article
|
Addressing the Crisis of Diagnosis and Management of Migraine in Primary Care: A Summary of the American Headache Society FrontLine Primary Care Advisory Board.
|
|
Academic Article
|
Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.
|
|
Academic Article
|
Biomarkers in Migraine.
|
|
Academic Article
|
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine.
|
|
Academic Article
|
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.
|
|
Academic Article
|
Efficacy and safety of fremanezumab in clinical trial participants aged =60?years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
|
|
Academic Article
|
Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.
|
|
Academic Article
|
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged =60?years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
|
|
Academic Article
|
OPTIMIZED ACUTE TREATMENT OF MIGRAINE IS ASSOCIATED WITH GREATER PRODUCTIVITY IN PEOPLE WITH MIGRAINE: RESULTS FROM THE CHRONIC MIGRAINE EPIDEMIOLOGY AND OUTCOMES (CAMEO) STUDY.
|
|
Academic Article
|
The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review.
|
|
Academic Article
|
Risk factors for migraine disease progression: a narrative review for a patient-centered approach.
|
|
Academic Article
|
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study.
|
|
Academic Article
|
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis.
|
|
Academic Article
|
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials.
|
|
Academic Article
|
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
|
|
Academic Article
|
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine.
|